多效生長(zhǎng)因子(PTN)活性蛋白
Active Pleiotrophin (PTN)
HARP; HBGF8; HBNF; NEGF1; Heparin Binding Growth Factor 8; Neurite Growth-Promoting Factor 1; Heparin Affin Regulatory Peptide; Heparin Binding Growth Associated Molecule
- 編號(hào)UAPB309Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 80%
- 等電點(diǎn)9.6
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說(shuō)明書 中文說(shuō)明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 756 ¥ 1890 ¥ 3780 ¥ 11340 ¥ 28350
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure. SDS-PAGE
-
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
活性實(shí)驗(yàn)
Pleiotrophin (PTN) is a 136 amino acid secreted heparin-binding cytokine that signals diverse functions, including lineage-specific differentiation of glial progenitor cells, neurite outgrowth, and angiogenesis. A considerable amount of research has been carried out to understand the mechanisms by which PTN regulates these events. PTN has now been shown to bind a diverse collection of receptors including Syndecan 1 (SDC1). A functional binding ELISA assay was conducted to detect the interaction of recombinant human PTN and recombinant human SDC1. Briefly, PTN were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to SDC1-coated (2 ug/ml, 100 ul/well) microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST and incubated for 1h with PTN pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50μL stop solution to the wells and read at 450nm immediately. The binding activity of recombinant human PTN and recombinant human SDC1 was shown in Figure 1, the EC50 was 3.47 ug/ml.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月，-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| UAPB309Hu01 | 多效生長(zhǎng)因子(PTN)活性蛋白 | Cell?culture;?Activity?Assays. |
| URPB309Hu02 | 多效生長(zhǎng)因子(PTN)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UAPB309Hu61 | 多效生長(zhǎng)因子(PTN)活性蛋白 | Cell?culture;?Activity?Assays. |
| URPB309Hu01 | 多效生長(zhǎng)因子(PTN)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UEPB309Hu61 | 多效生長(zhǎng)因子(PTN)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAB309Hu06 | 多效生長(zhǎng)因子(PTN)多克隆抗體 | WB; IHC; ICC; IP. |
| UPAB309Hu02 | 多效生長(zhǎng)因子(PTN)多克隆抗體 | WB; IHC; ICC; IP. |
| UPAB309Hu01 | 多效生長(zhǎng)因子(PTN)多克隆抗體 | WB; ICC/IF |
| ULAB309Hu81 | 多效生長(zhǎng)因子(PTN)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| ULAB309Hu71 | 多效生長(zhǎng)因子(PTN)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| UMAB309Hu22 | 多效生長(zhǎng)因子(PTN)單克隆抗體 | WB; IHC; ICC; IP. |
| USEB309Hu | 多效生長(zhǎng)因子(PTN)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| USCB309Hu | 多效生長(zhǎng)因子(PTN)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| ULMB309Hu | 多效生長(zhǎng)因子(PTN)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Oncogene | Suppression of lung adenocarcinoma through menin and polycomb gene-mediated repression of growth factor pleiotrophinMenin suppresses lung cancer through PTN [Nature: 2009273] |
| PLOS ONE | The Effects of Pleiotrophin in Proliferative Diabetic Retinopathy [Pubmed:25617851] |
| Infect Immun.? | Depletion of Phagocytic Cells during Nonlethal Plasmodium yoelii Infection Causes Severe Malaria Characterized by Acute Renal Failure in Mice. [Pubmed:26755155] |
| In Vivo | Evaluation of Serum Biomarkers (FGF-2, HGF, MIF and PTN) in Patients With Testicular Germ Cell Cancer [Pubmed: 31662522] |
